GC
SGMO

Globeflex Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Globeflex Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-697,583
Closed -$907K – 499
2023
Q2 		$907K Buy
+697,583
New +$953K 0.1% 188
2016
Q1 		– Sell
-35,561
Closed -$325K – 489
2015
Q4 		$325K Sell
35,561
-70,700
-67% -$545K 0.09% 274
2015
Q3 		$599K Buy
106,261
+21,561
+25% +$178K 0.13% 264
2015
Q2 		$939K Buy
84,700
+84,672
+302,400% +$1.09M 0.17% 234
2015
Q1 		$0 Sell
28
-34
-55% -$526 ﹤0.01% 589
2014
Q4 		$1K Sell
62
-8
-11% -$97 ﹤0.01% 460
2014
Q3 		$1K Buy
+70
New +$914 ﹤0.01% 479

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Globeflex Capital's SGMO Position: Q3 2023 in Review

Globeflex Capital sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2023, closing a stake of 697,583 shares — an estimated $907K sold.

Globeflex Capital first reported a position in SGMO in Q3 2014 and held it in 7 quarters. The position peaked at $939K in Q2 2015. 134 funds tracked by Wall St. Rank hold SGMO as of Q3 2023.

  • Globeflex Capital reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2023 after selling out during the quarter.
  • Globeflex Capital sold 697,583 SANGAMO THERAPEUTICS INC shares in Q3 2023, an estimated $907K.
  • Globeflex Capital first reported a position in SANGAMO THERAPEUTICS INC in Q3 2014 and held it in 7 quarters.
  • Globeflex Capital's SANGAMO THERAPEUTICS INC position peaked at $939K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2023.

Based on Globeflex Capital's 13F filing for Q3 2023, filed 13 Nov 2023.